Frontlight ResearchEarly access
CompletedPhase 2
A Study of ONO-1110 in Patients With Postherpetic Neuralgia
Key facts
- Who runs it
- Ono Pharmaceutical Co., Ltd.
- Where
- Japan31 sites in 1 countryChoose a country to see its sites
- Trial code
- NCT06708416
- JRCT2031240504
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 142 people enrolled
- Started
- 12 Feb 2025
- Ended
- 11 May 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- ONO-1110
- Placebo
- Record updated
- 15 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Japanese (both sexes)
- Age (at the time of informed consent): 18 years and older
- Outpatient
- Patients with persistent pain ≥3 months (90 days) after the onset of herpes zoster
- Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)
Who cannot take part
- Patients who previously underwent neurodestruction or neurosurgical therapy for PHN
- Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
- Patients with concurrent psychiatric diseases that may affect assessments in this study
- Patients with any skin condition related to the site of herpes zoster that may affect assessments in this study
- Patients with pain other than PHN that may affect assessments in this study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia
The 2 groups in the trial
- ONO-1110Treatment being tested
ONO-1110 tablets once a day
- PlaceboPlacebo, for comparison
Placebo tablets once daily
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Postherpetic Neuralgia
- Record updated
- 15 July 2026